Recently, a mouse model of hereditary tyrosinemia type I(HT1)caused by a point mutation of fumarylacetoacetate hydrolase (FAH) was phenotypically restored via Cas9‐mediated gene repair in vivo (Yin et al, 2014). Here, FAH is linked to Tyrosinemia type 1.